2015 CP Has Heart Cardiovascular Research Award recipients announced
TORONTO, Oct. 23, 2015 /CNW/ - The Heart and Stroke Foundation and
Canadian Pacific (CP) are proud to announce the 2015 CP Has Heart
Cardiovascular Award recipients - 10 Canadian cardiovascular research
projects that will receive funding because of a visionary partnership
between the Foundation and CP. This partnership, announced in May 2015,
is a bold initiative that will move cardiovascular research forward in
Canada, at a time when research funding from traditional sources has
been on the decline.
Through its CP Has Heart community investment program, CP committed $3
million over three years to support cardiovascular research with a
focus on multi-generational health. The research projects announced
today cover topics as diverse as preventing heart damage from viral
infections, personalizing treatments for a genetic disorder that can
prove fatal for Canadians under 30, and examining the impact of
fertility drugs on the heart health of women.
"This is the first time in the history of the Heart and Stroke
Foundation that a corporate partner has made such a forward-thinking
investment in Canadian cardiovascular research," says David Sculthorpe,
CEO of the Heart and Stroke Foundation. "CP's generous support will
propel medical advances by the Canadian cardiovascular community to
create longer, healthier futures for families from coast to coast."
Ray Johnson knows first-hand the impact of medical advances on families.
While he was in hospital recovering from triple bypass surgery, Ray's
daughter was admitted one floor away, in labour. Things quickly became
dire when the baby's heart rate registered off the charts. Baby Atli
entered this world with chaotic atrial tachycardia, an irregular heart
"Thanks to the Heart and Stroke Foundation, both my grandson and I have
benefited from treatments that extend the lives of patients of all
ages," says Ray. He is grateful for each day he spends with Atli and
the rest of his family.
Through its visionary corporate leadership, CP will help to write more
stories like Ray's. The CP Has Heart Cardiovascular Research Awards
will be presented to the recipients at the Canadian Cardiovascular
Congress on Sunday, October 25, 2015 in Toronto.
"The focus of our CP Has Heart program is to improve the heart health of
men, women and children across North America, particularly in those
communities in which our railroad operates," said Mark Wallace, VP
Corporate Affairs and Chief of Staff. "Our partnership with the Heart
and Stroke Foundation, and the CP Has Heart Cardiovascular Awards,
means the best minds in cardiology in Canada can continue to transform
lives and help create healthier communities today and for the future."
The award recipients were selected through the Heart and Stroke
Foundation's gold standard peer review process. In 2015, 454 grant
applications were received by the Foundation and peer reviewed by 150
volunteer experts. The CP Has Heart Cardiovascular award recipients
represent cardiovascular research excellence in Canada.
Canadian Pacific (TSX:CP)(NYSE: CP) is a transcontinental railway in
Canada and the United States with direct links to eight major ports,
including Vancouver and Montreal, providing North American customers a
competitive rail service with access to key markets in every corner of
the globe. CP is growing with its customers, offering a suite of
freight transportation services, logistics solutions and supply chain
expertise. Visit cpr.ca to see the rail advantages of Canadian Pacific.
About CP Has Heart
At CP we know that a railroad may serve as the arteries of a nation, but
at its heart is community. That's why through CP Has Heart, we're improving the heart health of men, women and children across
North America. Since its inception, CP Has Heart has committed more than $6 million dollars to heart health initiatives
in communities across Canada. And along the way, we're showing heart
whenever we can. Find out more on www.cpr.ca or @CPhasHeart.
About the Heart and Stroke Foundation
The Heart and Stroke Foundation's mission is to prevent disease, save
lives and promote recovery. A volunteer-based health charity, we strive
to tangibly improve the health of every Canadian family, every day.
Healthy lives free of heart disease and stroke. Together we will make
it happen. Learn how at heartandstroke.ca.
CP Has Heart Cardiovascular Award 2015 Recipients
Dr. John Dawson, University of Guelph
Hunting the cause of a potential killer
When a competitive athlete suddenly collapses and dies, the cause is
often hypertrophic cardiomyopathy (HCM), a thickening of the heart
muscle. This study examines how specific proteins can interact to cause
HCM in patients with an inherited defect in the heart protein cardiac
actin, with a goal to prevent and treat this life-threatening
Dr. John Eikelboom, McMaster University
Creating better outcomes for patients on blood thinners
Blood thinning medications to reduce the risk of clots are routinely
used to prevent heart attack and stroke, but they can also cause
bleeding. This study will identify the risk factors for bleeding in
patients receiving these medications, with an aim to develop new
strategies for preventing heart attack and stroke.
Dr. Slava Epelman, University of Toronto
How can we prevent heart damage from viral infections?
Viral infections can leave the heart damaged and vulnerable to develop
heart failure in adults and children. This study examines the role of
the heart's own immune cells in battling viral infections and how they
may actually contribute to heart damage through inflammation, with an
aim to find new therapies to protect the heart from damage.
Dr. Paul Kubes, University of Calgary
Microscopic technology will reveal keys to preventing blood vessel
Damage to the inner lining of blood vessels occurs in many types of
cardiovascular disease, yet we don't fully understand how or why this
happens. Using sophisticated microscopes, this study examines the
potential role of the body's own defenses in causing this damage which
could lead to more targeted treatments to prevent blood vessel damage.
Dr. Gregoire Le Gal, University of Ottawa
Building a better test to detect dangerous blood clots
When blood clots form in the leg veins, a fast, accurate diagnosis is
critical to avoid the potentially fatal risk of clots travelling to the
lungs. This study investigates a more accurate age-adjusted test to
help doctors diagnose and treat clots faster, saving lives and
preventing unnecessary blood-thinning therapy for patients who don't
Dr. Shubhayan Sanatani, University of British Columbia
Reducing the toll of a deadly heart defect
A heart rhythm disorder known as CPVT can kill as many as half of those
who have it by age 30. We know little about it, and who is at highest
risk for cardiac arrest and sudden death. This study is the first to
address CPVT on a large scale by establishing a detailed registry of
patients, including family history and blood samples, and could save
lives through personalized treatments.
Dr. Richard Schulz, University of Alberta
Targeted drugs could help promote better recovery from heart attack
When blood flow to the heart is blocked in a heart attack, permanent
damage and eventual heart failure can result - both from the blockage
and from its removal to restore normal flow. This investigation of how
the protein MMP-2 contributes to heart injury could lead to identifying
inhibitor drugs to prevent heart failure and save lives.
Dr. Craig Simmons, University of Toronto
Finding a treatment for diseased heart valves
When heart valves are diseased they stop functioning properly, putting
strain on the heart. This study investigates if a molecule called CNP
can help slow the progression of calcific aortic valve disease, with a
long-term goal to improve patients' quality of life.
Dr. Jacob Udell, University of Toronto
Do fertility drugs affect women's heart health?
More Canadian women are using fertility drugs to get pregnant, yet we
know little about their long-term effects. This is the first study of
the association between fertility treatment failure and the risk of
cardiovascular events that could lead to saving the lives of more
Dr. Shi Wu Wen, University of Ottawa
Could fertility treatments be linked to heart defects in some
Congenital heart defects occur when the heart or nearby blood vessels
don't develop normally before birth, affecting about 3,000 pregnancies
each year in Canada. This study is focused on the impact of assisted
reproductive technology to determine whether babies born to obese
mothers are more likely to have congenital heart defects than those
born to non-obese mothers.
SOURCE Canadian Pacific
For further information:
For more information or interviews, contact
416-467-9954, ext. 104
Director Media Relations, Canadian Pacific
Instagram or Twitter @CPhasHeart @TheHSF